Press Release | May 14, 2019 | BIO Announcements, Industry Analysis Reports, Human Health, Drug Development Process, Drug Discovery, Phase 1, Phase 2, Phase 3, Aging
Today, the Biotechnology Innovation Organization (BIO) released a new report, The State of Innovation in Highly Prevalent Chronic Diseases Volume IV: Alzheimer’s Disease Therapeutics, the fourth in a series on the innovation landscape of highly prevalent, chronic diseases. This volume takes an…